Health – Dr. Robert Kohn

What Qualifies as an Anxiety Disorder?

The recipient of an MD from the University of Chicago, Dr. Robert Kohn is a psychiatrist with a geriatric focus who leads a private practice in Providence, Rhode Island. Dr. Robert Kohn has also contributed to more than 100 scientific papers, including a publication titled “Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.”

In the United States, anxiety disorders are the most prevalent category of mental illness among adults. As of 2020, roughly 40 million adults suffered from at least one form of anxiety disorder. Anxiety disorder is an umbrella term for different illnesses that present with apprehension and fear. Panic disorder, social anxiety disorder, generalized anxiety disorder, PTSD, and obsessive-compulsive disorder are different types of anxiety disorders.

Anxiety in the middle of a tense circumstance is normal. When people are subjected to a large amount of stress, it is only natural for them to feel anxious, which does not mean they have an anxiety disorder. People suffering from anxiety disorders experience frequent apprehension in everyday situations, which is abnormal. For a person suffering from an anxiety disorder, panic attacks may be a recurring experience. Other noticeable symptoms include frequent sweating, enigmatic trembling, exhaustion, and avoiding places or things that trigger anxiety.

Treatment Gap is Increasing the Global Burden of Mental Disorders

An experienced psychiatrist who specializes in geriatrics, Dr. Robert Kohn has accumulated numerous honors and awards throughout the course of his four-decade career, including two teaching awards in geriatric psychiatry. Currently operating his own private practice in Providence, Dr. Robert Kohn diagnoses and treats seniors who are suffering from a variety of developmental and mental disorders.

The worldwide burden of mental disorders is linked to the emergence of illnesses at a young age, and a large treatment gap, among other things. The treatment gap for mental disorders refers to the net difference between individuals who require therapy and those who receive it. Only a small percentage of people with mental illnesses in the Americas, as everywhere in the globe, have been able to get treatment, and for many people, initial treatment is routinely delayed for years.

The key controllable element in reducing the worldwide burden of mental illnesses is closing the treatment gap and lowering the 12-month prevalence of mental disorders. Significant health and social consequences have been linked to a wide treatment gap. These include low educational attainment, minimized work competency, low-income attainment, and impairments in personal function. These consequences may worsen mental health.

WHO Highlights Disparity in Global Mental Health Care

Respected researcher, academic, and practicing psychiatrist Robert Kohn, MD, investigates diverse topics in geriatric and cultural psychiatry. In addition to serving as a visiting professor at universities in Portugal and Chile, Dr. Robert Kohn has also consulted with the World Health Organization on matters pertaining to global mental health.

In 2019, WHO established a special initiative to increase mental health care access to more than 100 million individuals in underserved nations. Mental health access is impeded in lower-middle and low-income countries due to a lack of infrastructure and trained professionals. For example, the number of available beds for in-patient mental health services in high-income nations outnumbers those in lower-income countries by 10 to 1.

Further, nearly half of the world’s inhabitants reside in nations with very low psychiatrist to patient ratios. Many nations also do not address mental health at the government level. While a third of wealthy countries have developed a suicide prevention strategy, none of the low-income countries have drafted a similar policy. In addition, half of all WHO member states do not have mental health laws in place to address disparities faced by people with mental illnesses.

Psychiatric Symptoms That Can Indicate Alzheimer’s

Medical researcher and geriatric psychiatrist Dr. Robert Kohn completed his residency at Brown University, where he later held a professorial post. Robert Kohn, MD, maintains a focus on disorders prevalent in geriatric psychiatry, including Alzheimer’s disease.

A study conducted by the University of California, San Francisco investigating the impact of abnormal proteins on the brain revealed that early-stage Alzheimer’s may first appear as psychiatric symptoms. Researchers studied the buildup of tau proteins in more than 1,000 individual brain tissue samples. This was combined with qualitative interviews with some brain donors’ close caregivers and family members.

The data suggest a link between tau proteins, known as tangles, and symptoms such as agitation and depression. Individuals who passed before the disease impacted their memory were more likely to have exhibited changes to their appetites and sleeping patterns before their death. Further, symptoms seem to progress as the tangles spread from the brainstem to the outer cortex. Investigators hope these findings will improve the diagnosis and treatment of early-stage Alzheimer’s.